Share 'PPMD to Fund $1 Million in Exon Skipping Projects'
PPMD announced today that it will fund up to $1 million in projects by mid-2014 focused on the development of antisense oligonucleotides or other techniques to skip exons that are not currently in clinical development, or for multi-exon skipping projects, including the skipping of duplications. A Request for Applications (RFA) has just been released.
Exon-skipping is a technique whe…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this